Master data| INID | Criterion | Field | Content | 
|---|
|  | Type of IP right | SART | Patent | 
|  | Status | ST | Not pending/lapsed | 
| 21 | DE file number | DAKZ | 602 49 982.8 | 
| 96 | EP file number | EAKZ | 18 15 5724.0 | 
| 97 | EP publication number | EPN | 3342411 | 
| 54 | Designation/title | TI | RAPAMYCIN-DERIVAT ZUR BEHANDLUNG VON BAUCHSPEICHELDRÜSENKREBS | 
| 51 | IPC main class | ICM (ICMV)
 | A61K 31/436 (2006.01) | 
| 51 | IPC secondary class(es) | ICS (ICSV)
 | A61P 35/00 (2006.01) | 
| 22 | DE application date | DAT | Feb 18, 2002 | 
| 96 | EP application date | EAT | Feb 18, 2002 | 
| 43 | Date of first publication | OT | Jul 4, 2018 | 
|  | Date of publication of grant | PET | Aug 21, 2019 | 
| 71/73 | Applicant/owner | INH | Novartis Pharma AG, Basel, CH | 
| 72 | Inventor | IN | Lane, Heidi, 4106 Therwill, CH; O`Reilly, Terence, 4057 Basel, CH; Wood, Jeanette Marjorie, 4105 Biel-Benken, CH | 
|  | Address for service |  | Novartis Pharma AG, 4056 BASEL, CH | 
| 33 31
 32
 
 | Foreign priority | PRC PRNA
 PRDA
 
 | GB 0124957
 Oct 17, 2001
 
 | 
| 33 31
 32
 
 | Foreign priority | PRC PRNA
 PRDA
 
 | GB 0104072
 Feb 19, 2001
 
 | 
|  | Patent division in charge |  | 44 | 
| 21 | File number of protection certificate | ZAKZ | 12 2020 000 008.6 | 
| 97 | EP language of publication | ELANG | EN - Englisch | 
| 84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR | 
|  | Published EP/WO documents | EPWOPN | Original document: 
EP000003342411A1 Searchable text: 
EP000003342411A1
 Original document: 
EP000003342411B1
 Searchable text: 
EP000003342411B1
 | 
| 43 | Date of first publication | EVT | Jul 4, 2018 | 
|  | Date of the first transfer into DPMAregister | EREGT | Jul 4, 2018 | 
|  | Date of the (most recent) update in DPMAregister | REGT | Feb 8, 2024 (Show all update days)(Hide all update days)
 Feb 8, 2024; Jan 4, 2024; Feb 20, 2022; Feb 12, 2021; Jul 16, 2020; Jun 25, 2020; Mar 5, 2020; Feb 14, 2020; Oct 17, 2019; Sep 12, 2019; Aug 23, 2019; Aug 3, 2019; Aug 1, 2019; Apr 4, 2019Historical data not available for this/these date(s)
Jul 4, 2018
 Date of the first transfer into DPMAregister
 | 
View procedures  New applicant/owner details (No.: 6)| INID | Criterion | Field | Content
Close details | 
|---|
|  | Type of procedure | VART | New applicant/owner details | 
|  | Legal/procedural status | VST | New applicant/owner details | 
|  | Date of legal/procedural status | VSTT | Jun 24, 2020 | 
|  | Issue number | HN | 31 | 
|  | Year | PJ | 2020 | 
|  | Publication date | VT | Jul 30, 2020 | 
|  | Type of publication | PART | Bibliographic data | 
|  | Part | HT | Part 3 | 
| 71/73 | Applicant/owner | INH | Novartis Pharma AG, Basel, CH | 
| 71/73 | Previous applicant/owner | INHF | Novartis International Pharmaceutical AG, Basel, CH, Novartis Pharma AG, Basel, CH | 
|  | Date of update of the procedure | REGT | Jul 16, 2020 |